HU9702479D0 - New polymorphe modification of doxazosin-mesylate - Google Patents
New polymorphe modification of doxazosin-mesylateInfo
- Publication number
- HU9702479D0 HU9702479D0 HU9702479A HUP9702479A HU9702479D0 HU 9702479 D0 HU9702479 D0 HU 9702479D0 HU 9702479 A HU9702479 A HU 9702479A HU P9702479 A HUP9702479 A HU P9702479A HU 9702479 D0 HU9702479 D0 HU 9702479D0
- Authority
- HU
- Hungary
- Prior art keywords
- polymorphe
- doxazosin
- mesylate
- modification
- new
- Prior art date
Links
- VJECBOKJABCYMF-UHFFFAOYSA-N doxazosin mesylate Chemical compound [H+].CS([O-])(=O)=O.C1OC2=CC=CC=C2OC1C(=O)N(CC1)CCN1C1=NC(N)=C(C=C(C(OC)=C2)OC)C2=N1 VJECBOKJABCYMF-UHFFFAOYSA-N 0.000 title 1
- 229960000220 doxazosin mesylate Drugs 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96120602A EP0849265A1 (de) | 1996-12-20 | 1996-12-20 | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9702479D0 true HU9702479D0 (en) | 1998-03-02 |
HUP9702479A2 HUP9702479A2 (hu) | 1999-04-28 |
HUP9702479A3 HUP9702479A3 (en) | 1999-06-28 |
Family
ID=8223530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9702479A HUP9702479A3 (en) | 1996-12-20 | 1997-12-16 | New polymorphous form of doxazosin-mesylate (form ii.), process for it's preparation and pharmaceutical compositions containing the same |
Country Status (11)
Country | Link |
---|---|
US (1) | US6133269A (hu) |
EP (1) | EP0849265A1 (hu) |
JP (1) | JPH10182640A (hu) |
KR (1) | KR19980064287A (hu) |
AU (1) | AU724705B2 (hu) |
CA (1) | CA2224884A1 (hu) |
HU (1) | HUP9702479A3 (hu) |
IL (1) | IL122631A (hu) |
NZ (1) | NZ329405A (hu) |
TW (1) | TW466239B (hu) |
ZA (1) | ZA9710633B (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59611417D1 (de) * | 1996-12-20 | 2007-03-29 | Heumann Pharma Gmbh & Co | Neue polymorphe Form von Doxazosinmesylat (Form III) |
DE19800214A1 (de) | 1998-01-06 | 1999-07-15 | Knoll Ag | Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür |
ES2164520B1 (es) | 1999-03-16 | 2003-04-01 | Medichem Sa | "procedimiento de obtencion del polimorfo a del mesilato de doxazosina" |
DE19912573A1 (de) * | 1999-03-19 | 2000-09-21 | Knoll Ag | Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D |
US8383627B2 (en) | 2007-12-24 | 2013-02-26 | Cipla Limited | Crystalline polymorph of doxazosin mesylate (form IV) and process for preparation thereof |
KR101001182B1 (ko) | 2010-06-01 | 2010-12-15 | (주)아이소텍 | 혈당측정장치에 사용하는 스트립 |
CN109988158A (zh) * | 2018-01-03 | 2019-07-09 | 合肥立方制药股份有限公司 | X晶型、含有x晶型的多沙唑嗪甲磺酸盐及其制备方法和用途 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2699054A (en) * | 1953-10-09 | 1955-01-11 | Lloyd H Conover | Tetracycline |
US4092315A (en) * | 1976-03-01 | 1978-05-30 | Pfizer Inc. | Novel crystalline forms of prazosin hydrochloride |
GB1591490A (en) * | 1977-08-04 | 1981-06-24 | Abbott Lab | 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate |
US4188390A (en) | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
DK154082C (da) * | 1977-11-05 | 1989-02-27 | Pfizer | Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf |
ATE72244T1 (de) * | 1986-03-21 | 1992-02-15 | Heumann Pharma Gmbh & Co | Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung. |
EP0253554A3 (en) * | 1986-07-15 | 1988-07-20 | Pfizer Inc. | Controlled release drug-containing fibers |
US5196410A (en) * | 1986-10-31 | 1993-03-23 | Pfizer Inc. | Transdermal flux enhancing compositions |
MY102980A (en) * | 1986-10-31 | 1993-03-31 | Pfizer | Transdermal flux enhancing compositions |
US4837111A (en) * | 1988-03-21 | 1989-06-06 | Alza Corporation | Dosage form for dispensing drug for human therapy |
US5023085A (en) * | 1989-11-29 | 1991-06-11 | Pfizer Inc. | Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
EP0459666B1 (en) * | 1990-05-31 | 1994-11-09 | Pfizer Inc. | Medicaments against impotence |
CA2077252C (en) * | 1992-08-31 | 2001-04-10 | Khashayar Karimian | Methods of making ureas and guanidines, and intermediates therefor |
WO1994009786A1 (en) * | 1992-11-04 | 1994-05-11 | Sepracor, Inc. | Methods and compositions of (+) doxazosin for the treatment of hypertension |
AU5457694A (en) * | 1992-11-04 | 1994-05-24 | Sepracor, Inc. | Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
US5294615A (en) * | 1993-04-29 | 1994-03-15 | Abbott Laboratories | Terazosin polymorph and pharmaceutical composition |
US5412095A (en) * | 1993-04-29 | 1995-05-02 | Abbott Laboratories | Terazosin monohydrochloride and processes and intermediate for its production |
JPH07206857A (ja) * | 1993-12-28 | 1995-08-08 | Synthelabo Sa | アルフゾシン塩酸塩の二水和物 |
US5504207A (en) * | 1994-10-18 | 1996-04-02 | Abbott Laboratories | Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
US5587377A (en) * | 1995-10-24 | 1996-12-24 | Invamed, Inc. | Terazosin crystalline polymorph and pharmaceutical compositions thereof |
DE59611417D1 (de) * | 1996-12-20 | 2007-03-29 | Heumann Pharma Gmbh & Co | Neue polymorphe Form von Doxazosinmesylat (Form III) |
-
1996
- 1996-12-20 EP EP96120602A patent/EP0849265A1/de not_active Withdrawn
-
1997
- 1997-01-01 ZA ZA9710633A patent/ZA9710633B/xx unknown
- 1997-12-03 TW TW086118158A patent/TW466239B/zh not_active IP Right Cessation
- 1997-12-16 IL IL12263197A patent/IL122631A/xx not_active IP Right Cessation
- 1997-12-16 CA CA002224884A patent/CA2224884A1/en not_active Abandoned
- 1997-12-16 HU HU9702479A patent/HUP9702479A3/hu unknown
- 1997-12-16 NZ NZ329405A patent/NZ329405A/en not_active IP Right Cessation
- 1997-12-17 US US08/992,474 patent/US6133269A/en not_active Expired - Lifetime
- 1997-12-17 JP JP9364070A patent/JPH10182640A/ja not_active Withdrawn
- 1997-12-17 KR KR1019970070178A patent/KR19980064287A/ko not_active Application Discontinuation
- 1997-12-18 AU AU48448/97A patent/AU724705B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA2224884A1 (en) | 1998-06-20 |
TW466239B (en) | 2001-12-01 |
KR19980064287A (ko) | 1998-10-07 |
US6133269A (en) | 2000-10-17 |
IL122631A0 (en) | 1998-08-16 |
JPH10182640A (ja) | 1998-07-07 |
ZA9710633B (en) | 1998-11-11 |
AU724705B2 (en) | 2000-09-28 |
IL122631A (en) | 2000-02-29 |
AU4844897A (en) | 1998-06-25 |
EP0849265A1 (de) | 1998-06-24 |
NZ329405A (en) | 1998-09-24 |
HUP9702479A3 (en) | 1999-06-28 |
HUP9702479A2 (hu) | 1999-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL329875A1 (en) | Derivatives of carbolin | |
PL329195A1 (en) | Derivatives of 6-phenylpyridol-2-amine | |
HK1018833A1 (en) | Document of value | |
PL327998A1 (en) | Novel derivatives of 19-nor-pregnene | |
HU9700328D0 (en) | New heteroaryl-oxazolidinones | |
GB9715519D0 (en) | Variety of different sources | |
GB9418762D0 (en) | Use of substituted cyclopentane-DI-and-triones | |
HU9700071D0 (en) | Use of muramilpeptides | |
HU9702480D0 (en) | New polymorphe modification of doxazosin-mesylate | |
EP0895545A4 (en) | A NEW PROTEIN, TRAF 6 | |
CY2590B2 (en) | Preparation of 1-butyl-4-piperidinylmethylamine | |
GB9602704D0 (en) | Structure of perculator | |
HU9702479D0 (en) | New polymorphe modification of doxazosin-mesylate | |
GB2328397B (en) | Manufacture of elongate members | |
PL317319A1 (en) | Oxidative amonolysis of alkylopyridines | |
PL313849A1 (en) | Beta-aminoesters of o-hydrobenzylamides | |
PL328019A1 (en) | Novel phenantidines | |
TW358610U (en) | Improvement of inter-com | |
TW304520U (en) | Improved structure of groyne | |
TW306561U (en) | Improved structure of wind-stopping block | |
TW303654U (en) | Additional improved structure of coat-stand | |
TW357554U (en) | Improvement of shinguards | |
GB2310852B (en) | Carboxylatocomplexes of Cobalt | |
GB9623330D0 (en) | New improved ringpull | |
TW303008U (en) | Improved structure of hanged-type lamps |